Recursion Pharmaceuticals (RXRX) Jumps 31% On Next-Gen AI
We recently published a list of 15 Stocks That Stole The Show Last Week.
Posts Tagged ‘NASDAQ:RXRX’
Why Recursion Pharmaceuticals (RXRX) Soared On Friday
We recently published a list of 10 Stocks Are Dominating Like Wall Street Titans. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.
Why Skyrocketed Recursion Pharmaceuticals, Inc. (RXRX) Today
We recently published a list of These 10 Stocks Are On Fire Right Now. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.
Was Jim Cramer Right About Recursion Pharmaceuticals, Inc. (RXRX)?
We recently published a list of Did Jim Cramer Nail or Miss These 11 Stock Predictions? In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.
Did Jim Cramer Nail or Miss These 11 Stock Predictions?
During the most recent episode of Mad Money, which aired on Tuesday the 27th of May, Jim Cramer opened with a passionate defense of the artificial intelligence boom, warning viewers...
10 Most Popular AI Stocks to Avoid Now
Over the last two years, artificial intelligence has been the central theme driving equities to record highs amid expectations that its technological innovations will change how...
13 Best Artificial Intelligence Stocks Under $50 to Buy Now
On May 8, Dan Ives of Wedbush Securities joined CNBC's 'Squawk on the Street' to discuss his bullish outlook on the AI sector and tech.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2025 Earnings Call Transcript
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2025 Earnings Call Transcript May 5, 2025Recursion Pharmaceuticals, Inc. misses on earnings expectations.
Did Jim Cramer Nail All These 9 Stock Predictions?
“When you see a grizzly bear in Yellowstone National Park, you call a park ranger because these bears are dangerous… but the grizzlies turn into teddy bears when the rangers...
Jim Cramer Hints at a Bigger Agenda Behind Tariffs and Breaks Down These 7 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer suggested the recent tariffs might not simply be about economic leverage.
12 Best AI Stocks to Invest in According to Reddit
Jensen Huang had previously estimated that practical quantum computing would be 15 to 30 years away, but he recently revised this timeline to 5 to 15 years.
Jim Cramer’s Latest Lightning Round: 8 Stocks in Focus
On Friday, Jim Cramer, host of Mad Money, addressed the current state of the stock market, giving a cautious recommendation to investors.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2024 Earnings Call Transcript February 28, 2025Recursion Pharmaceuticals, Inc. misses on earnings expectations.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may...
10 Best Performing Healthcare Stocks So Far in 2025
Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year.
Top 10 AI Stocks Buzzing on Latest News
Investors are continuing to assess the impact of new LLMs in the AI industry. X.
5 Stocks Jensen Huang’s Company is Betting On
Nvidia has a reputation for identifying high-quality companies in their initial stages and betting on their success.
12 Cheap AI Stocks to Buy in 2025
Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with significant risks.
Top 10 Medical AI Stocks on Wall Street’s Radar
Investments in the global healthcare industry have ramped up sharply since the COVID-19 pandemic.
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.
Blackrock’s 30 Most Important AI Stocks
In the third quarter of 2024, investment titan Blackrock released a commentary on the market outlook for artificial intelligence heading into the closing months of the year, stressing...
Jim Cramer’s Latest Calls: Top 10 Stocks
"I want to discuss Bitcoin, really. I do—not to the detriment of stocks but in addition to stocks. I come to praise Bitcoin, not buy it.
10 AI News Investors Probably Missed
As artificial intelligence continues to reshape industries, experts are increasingly focusing on how its integration will impact investment strategies.
10 Worst ARK Stocks To Buy According to Short Sellers
Cathie Wood of ARK Investment is one of Wall Street's most well-known hedge fund bosses.
Jim Cramer’s Lightning Round: 7 Stocks to Watch
Jim Cramer, the host of Mad Money, recently offered his views on several key topics, including Big Tech stocks and cryptocurrency.
8 Best Small-Cap Growth Stocks to Buy According to Analysts
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
10 Worst ARK Stocks To Buy According To Short Sellers
Investing comes in all sizes and flavors.
10 Best Medical AI Companies
Generally, when you hear the term "artificial intelligence," your mind jumps straight to semiconductor and big tech companies that have been making huge profits as a result of...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2024 Earnings Call Transcript
Chris Gibson: Hi, everybody. My name is Chris Gibson, Co-Founder and CEO of Recursion, delighted to be joining you on our L(earnings) today.
Hedge Funds are Loading Up on This NVIDIA Corp (NVDA) Partner Stock
Recursion Pharmaceuticals is an NVIDIA Corp (NASDAQ:NVDA) partner that will use the semiconductor giant's chips and technology for drug discovery.
7 Best Under-The-Radar AI Stocks Hedge Funds are Buying
The AI-led stock rally that rewarded mega-cap technology stocks has finally started to trickle down to other industry players that were seemingly not related to the AI and tech...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2024 Earnings Call Transcript
Chris Gibson: Hi, everybody.
Jim Cramer is Recommending These 10 Stocks Heading Into May 2024
In this article, we will take a detailed look at the latest stocks Jim Cramer is recommending.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2023 Earnings Call Transcript
Chris Gibson: Hi, everybody. I’m Chris Gibson, Co-Founder and CEO of Recursion, and I am really excited to welcome you to our first ever Learnings Call here at Recursion.
Cathie Wood Was Buying These 5 Stocks for 2024
This article presents an overview of Cathie Wood Was Buying These 5 Stocks for 2024. For a detailed overview of such stocks, read our article, Cathie Wood Was Buying These ...
40 Cities with the Lowest Life Expectancy in the US
In this article, we look at 40 cities with the lowest life expectancy in the US.
40 Cities with the Highest Life Expectancy in the US
In this article, we look at 40 Cities With The Highest Life Expectancy In The US.
Billionaire Druckenmiller’s 5 Stocks Picks with Huge Upside Potential
In this piece, we will take a look at billionaire Druckenmiller's 5 stocks picks with huge upside potential. If you want to read our introduction to Mr.
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Billionaire Stan Druckenmiller’s Small-Cap Stock Picks: Top 5 Stocks
In this piece, we will take a look at billionaire Stanley Druckenmiller's top five small-cap stock picks.
Top 10 Growth Stocks in Biotech
The biotech industry encompasses a wide range of fields, including genetic engineering, biomanufacturing, bioinformatics, and synthetic biology.
5 AI Healthcare Stocks To Buy
AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian company that is operating in the domain of human antibodies.
Harvard University Stock Portfolio: Top 10 Picks
In this article, we discuss the top 10 picks of the Harvard University stock portfolio.
Is Recursion Pharmaceuticals (RXRX) a Worthy Investment?
Lux Capital, an investment management firm, published its second quarter 2022 investor letter – a copy of which can be downloaded here.
Harvard University’s Latest Portfolio: 5 Best Biotech Stock Picks
In this article, we will look at Harvard University's latest stock portfolio and list its 5 best biotech stock picks.
Cathie Wood’s Top 10 Buys in July
In the beginning of July, Cathie Wood of ARK Investment Management admitted that while her predictions about inflation were wrong, the US seems to be heading towards a deflationary...
9 Healthcare Stocks to Invest In Today According to Stanley Druckenmiller
In this piece, we will take a look at the nine healthcare stocks to invest in today according to Stanley Druckenmiller.
5 Biotech Stocks to Buy Today According to Kerr Neilson’s Platinum Asset Management
In this piece, we will take a look at the five biotechnology stocks to buy today according to Kerr Neilson's Platinum Asset Management.
Analysts Are Downgrading These 10 Pharmaceutical Stocks
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
5 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
In this article, we will look at 5 pharmaceutical stocks to buy now according to billionaire Kerr Neilson.
